Trial · NCT03122860
Results by group54
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 54
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline Osteoarthritis (OA) Pain in the Target Knee as Assessed by the Weekly Average of Daily Pain Numeric Rating Scale (NRS) | 0.03 mg SM04690 | -2.77 | Standard Deviation 2.44 | score on a scale | |
| Change From Baseline Osteoarthritis (OA) Pain in the Target Knee as Assessed by the Weekly Average of Daily Pain Numeric Rating Scale (NRS) | 0.07 mg SM04690 | -2.93 | Standard Deviation 2.21 | score on a scale | |
| Change From Baseline Osteoarthritis (OA) Pain in the Target Knee as Assessed by the Weekly Average of Daily Pain Numeric Rating Scale (NRS) | 0.15 mg SM04690 | -2.43 | Standard Deviation 2.18 | score on a scale | |
| Change From Baseline Osteoarthritis (OA) Pain in the Target Knee as Assessed by the Weekly Average of Daily Pain Numeric Rating Scale (NRS) | 0.23 mg SM04690 | -3.03 | Standard Deviation 2.43 | score on a scale | |
| Change From Baseline Osteoarthritis (OA) Pain in the Target Knee as Assessed by the Weekly Average of Daily Pain Numeric Rating Scale (NRS) | Placebo | -2.26 | Standard Deviation 2.44 | score on a scale | |
| Change From Baseline Osteoarthritis (OA) Pain in the Target Knee as Assessed by the Weekly Average of Daily Pain Numeric Rating Scale (NRS) | Sham | -2.21 | Standard Deviation 2.46 | score on a scale | |
| Change From Baseline OA Pain in the Target Knee as Assessed by Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscore (WOMAC Pain) | 0.03 mg SM04690 | -27.6 | Standard Error 22.8 | score on a scale | |
| Change From Baseline OA Pain in the Target Knee as Assessed by Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscore (WOMAC Pain) | 0.07 mg SM04690 | -30.0 | Standard Error 22.5 | score on a scale | |
| Change From Baseline OA Pain in the Target Knee as Assessed by Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscore (WOMAC Pain) | 0.15 mg SM04690 | -24.7 | Standard Error 21.6 | score on a scale | |
| Change From Baseline OA Pain in the Target Knee as Assessed by Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscore (WOMAC Pain) | 0.23 mg SM04690 | -33.3 | Standard Error 22.9 | score on a scale | |
| Change From Baseline OA Pain in the Target Knee as Assessed by Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscore (WOMAC Pain) | Placebo | -25.5 | Standard Error 25.8 | score on a scale | |
| Change From Baseline OA Pain in the Target Knee as Assessed by Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscore (WOMAC Pain) | Sham | -22.5 | Standard Error 24.6 | score on a scale | |
| Change From Baseline OA Function in the Target Knee as Assessed by WOMAC Physical Function Subscore (WOMAC Function) | 0.03 mg SM04690 | -27.7 | Standard Deviation 21.1 | score on a scale | |
| Change From Baseline OA Function in the Target Knee as Assessed by WOMAC Physical Function Subscore (WOMAC Function) | 0.07 mg SM04690 | -29.3 | Standard Deviation 23.0 | score on a scale | |
| Change From Baseline OA Function in the Target Knee as Assessed by WOMAC Physical Function Subscore (WOMAC Function) | 0.15 mg SM04690 | -23.6 | Standard Deviation 21.6 | score on a scale | |
| Change From Baseline OA Function in the Target Knee as Assessed by WOMAC Physical Function Subscore (WOMAC Function) | 0.23 mg SM04690 | -32.4 | Standard Deviation 22.1 | score on a scale | |
| Change From Baseline OA Function in the Target Knee as Assessed by WOMAC Physical Function Subscore (WOMAC Function) | Placebo | -24.9 | Standard Deviation 23.7 | score on a scale | |
| Change From Baseline OA Function in the Target Knee as Assessed by WOMAC Physical Function Subscore (WOMAC Function) | Sham | -23.8 | Standard Deviation 23.7 | score on a scale | |
| Change From Baseline in Medial Joint Space Width (mJSW) of the Target Knee | 0.03 mg SM04690 | 0.02 | Standard Deviation 0.72 | mm | |
| Change From Baseline in Medial Joint Space Width (mJSW) of the Target Knee | 0.07 mg SM04690 | -0.11 | Standard Deviation 0.53 | mm |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03122860/results